Israeli strikes kill 15 Palestinians in Gaza school, nine West Bank militants
By Nidal al-Mughrabi and Ali Sawafta CAIRO/RAMALLAH (Reuters) -An Israeli airstrike on a school sheltering...
Business
Peter Schiff Predicts Japan’s Bitcoin Exit as Price Drops: Details
U.Today – , the largest cryptocurrency by market value, fell below $61,000 in Saturday’s trading...
Venezuela election marches must be peaceful, says OAS body
By Mircely Guanipa and Vivian Sequera CARACAS (Reuters) – The Organization of American States on...
Olympics-Gymnastics-Biles soars to third gold medal of Paris Olympics with vault triumph
By Rory Carroll PARIS (Reuters) -Simone Biles won the vault final on Saturday to clinch...
Duke Energy Florida readies for approaching storm, mobilizes 3,000 resources ready to respond to power outages, heavy rainfall
Prepare now for possible power outages as impacts may be felt broadly across Duke Energy...
Abrdn finance chief Jason Windsor to replace Stephen Bird as CEO, Financial Times reports
(Reuters) – Abrdn finance chief Jason Windsor is the front-runner to become the next chief...
Trump proposes to debate VP Harris on Fox News on Sept. 4
(Reuters) -Republican presidential nominee Donald Trump proposed to debate Democratic U.S. Vice President Kamala Harris...
Warning: Warren Buffet is selling stocks. A lot
Warren Buffett’s Berkshire Hathaway (NYSE:) was aggressively cutting his exposure to equities in the second...
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that...
